Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Levian

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
JAMA Dermatology|September 7, 2022
A Rapidly Enlarging Facial AbscessBrandon Levian, Alessandra Chen, Brandon L Adler
Contact Dermatitis|October 17, 2023
Out of REACH: Allergic contact dermatitis to nickel in an Apple WatchBrandon Levian, Grace C Chan, Brandon L Adler
JAAD International|November 11, 2024
Pseudopemphigoid: A systematic reviewBrandon Levian, Syedah S Hussaini, David T Woodley, et al.
International Journal of Molecular Sciences|October 28, 2023
Why Are There So Few FDA-Approved Therapeutics for Wound Healing?Mei Chen, Cheng Chang, Brandon Levian, et al.
Molecular Therapy. Nucleic Acids|November 10, 2025
Novel eRF3a degrader enhances gentamicin-induced premature termination codon readthrough in epidermolysis bullosaKathleen L Miao, Brandon Levian, Yingping Hou, et al.
Dermatology Online Journal|September 24, 2025
Enchondroma of the toe presenting as clubbing and painless longitudinal erythronychiaBrandon Levian, Vignesh Ravi, Daniel Mosallaei, et al.
Molecular Therapy. Nucleic Acids|October 11, 2024
Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosaBrandon Levian, Yingping Hou, Xin Tang, et al.
Dermatology Online Journal|February 23, 2026
An atypical case of granulomatosis with polyangiitis in a 15-year-old girl presenting with pyoderma gangrenosum-like ulcers on the faceBrandon Levian, Vignesh Ravi, Kevin K Wu, et al.
The British Journal of Dermatology|February 17, 2024
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trialDavid T Woodley, Michelle Hao, Andrew Kwong, et al.
JAMA Dermatology|March 2, 2022
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense VariantsDaniel Mosallaei, Michelle Hao, Richard J Antaya, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
JAMA Dermatology|September 7, 2022
A Rapidly Enlarging Facial AbscessBrandon Levian, Alessandra Chen, Brandon L Adler
Contact Dermatitis|October 17, 2023
Out of REACH: Allergic contact dermatitis to nickel in an Apple WatchBrandon Levian, Grace C Chan, Brandon L Adler
JAAD International|November 11, 2024
Pseudopemphigoid: A systematic reviewBrandon Levian, Syedah S Hussaini, David T Woodley, et al.
International Journal of Molecular Sciences|October 28, 2023
Why Are There So Few FDA-Approved Therapeutics for Wound Healing?Mei Chen, Cheng Chang, Brandon Levian, et al.
Molecular Therapy. Nucleic Acids|November 10, 2025
Novel eRF3a degrader enhances gentamicin-induced premature termination codon readthrough in epidermolysis bullosaKathleen L Miao, Brandon Levian, Yingping Hou, et al.
Dermatology Online Journal|September 24, 2025
Enchondroma of the toe presenting as clubbing and painless longitudinal erythronychiaBrandon Levian, Vignesh Ravi, Daniel Mosallaei, et al.
Molecular Therapy. Nucleic Acids|October 11, 2024
Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosaBrandon Levian, Yingping Hou, Xin Tang, et al.
Dermatology Online Journal|February 23, 2026
An atypical case of granulomatosis with polyangiitis in a 15-year-old girl presenting with pyoderma gangrenosum-like ulcers on the faceBrandon Levian, Vignesh Ravi, Kevin K Wu, et al.
The British Journal of Dermatology|February 17, 2024
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trialDavid T Woodley, Michelle Hao, Andrew Kwong, et al.
JAMA Dermatology|March 2, 2022
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense VariantsDaniel Mosallaei, Michelle Hao, Richard J Antaya, et al.
Pageof 2